financetom
Business
financetom
/
Business
/
Warner Music Group Expected to See Accelerating Growth in 2026, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Warner Music Group Expected to See Accelerating Growth in 2026, UBS Says
Jul 10, 2025 12:24 PM

02:57 PM EDT, 07/10/2025 (MT Newswires) -- Warner Music Group ( WMG ) is expected to continue low single-digit growth in the second half of fiscal 2025 and will see accelerating revenue in fiscal 2026, supported by new wholesale deals and cost-saving initiatives, UBS Securities said in an earnings preview emailed Thursday.

The firm said it expects Warner's fiscal Q3 revenue to total $1.58 billion, up 2% from a year earlier, while operating income before depreciation and amortization is forecast to grow 5% to $339 million.

Recorded Music revenue in fiscal Q3 is expected to be flat with less than 1% growth in streaming due to tough comparisons and past pricing effects, while a rebound is anticipated in Q4 because of recent market share gains, UBS said.

The brokerage said music publishing revenue will likely grow 5% during the quarter, with streaming up 6%, and a recent renewal with Spotify ( SPOT ) could drive further upside later.

Warner is targeting $265 million in annual cost savings by fiscal year 2027, with most benefits flowing to margins, according to the note.

UBS has a buy rating on the company's stock with a $38 price target.

Price: 30.25, Change: +0.26, Percent Change: +0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Morningstar Bank of Canada's Possible Rate Cuts This Year
Morningstar Bank of Canada's Possible Rate Cuts This Year
Jan 3, 2025
07:13 AM EST, 01/03/2025 (MT Newswires) -- After the Bank of Canada lowered interest rates five times in 2024, investors and consumers can expect more such moves this year, said Morningstart. However, analysts say the BoC's pace of easing will likely be much more modest next year, wrote Morningstar in a note published on Tuesday. Canada's central bank cut rates...
BJ's Restaurants Taps Panera Bread Founder For Growth: Details
BJ's Restaurants Taps Panera Bread Founder For Growth: Details
Jan 3, 2025
BJ’s Restaurants, Inc. has announced a new cooperation agreement with Act III Holdings and affiliates of Ronald M. Shaich, a prominent restaurant industry figure. Act III, led by Shaich, who is also the founder of Panera Bread and Chair of Cava Group, will work closely with BJ’s leadership team to drive the company’s growth and strategic vision. Lea Anne S....
JBT Marel Settles Acquisition of Marel Shares, Begins Trading Under New Ticker Symbol
JBT Marel Settles Acquisition of Marel Shares, Begins Trading Under New Ticker Symbol
Jan 3, 2025
07:14 AM EST, 01/03/2025 (MT Newswires) -- JBT Marel (JBT, JBTM) said Friday it completed the settlement of its acquisition of all issued and outstanding shares of Marel that were tendered before the Dec. 20 expiration of its voluntary takeover offer. Shares of the combined company begin trading Friday under the new ticker symbol JBTM on the New York Stock...
GSK Says China Approval Secured for Nucala to Treat Adults With Chronic Rhinosinusitis With Nasal Polyps
GSK Says China Approval Secured for Nucala to Treat Adults With Chronic Rhinosinusitis With Nasal Polyps
Jan 3, 2025
07:17 AM EST, 01/03/2025 (MT Newswires) -- GSK (GSK) said Friday that the China National Medical Products Administration has approved Nucala, or mepolizumab, as an add-on therapy with intranasal corticosteroids to treat adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps. The company said the approval was based on the results of a phase 3 trial of mepolizumab in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved